Violence in ICU: Outcomes, Lessons, and Experiences of ICU Team (The VIOLENT-Study)
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Apr 7, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The VIOLENT-Study is a research project that looks into how healthcare workers in intensive care units (ICUs) in Switzerland feel and respond to violence from patients. The study aims to understand the experiences of nurses and doctors in these high-stress environments, where they sometimes face challenging situations with patients. By gathering this information, the researchers hope to improve conditions for healthcare workers and better support them in their roles.
To participate in this study, individuals must be nurses or doctors currently working in Swiss ICUs and willing to share their experiences. If they choose to take part, they can expect to share their thoughts and feelings about handling violence at work. This study is currently recruiting participants, and anyone who does not consent to participate will not be included. Your involvement could help shape better workplace practices and safety measures for those who care for critically ill patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consenting nurses and physicians currently working in Swiss intensive care units
- • Nurses and physicians consenting to participate will be included
- Exclusion Criteria:
- • Nurses and physicians who do not consent
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, Basel Stadt, Switzerland
Patients applied
Trial Officials
Raoul Sutter, Prof. Dr. med.
Principal Investigator
University Hospital Basel, Department of Acute Medicine, Intensive Care Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported